Cocrystal Pharma Provides Business Update and Reports Third Quarter 2026 Financial Results
BOTHELL, Wash., Nov. 15, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. NASDAQ:COCP (“Cocrystal” or the “Company”) provides updates on its antiviral product pipeline and business activities and reports financial results for the three and nine months ended September 30, 2026.“Dosing the last subjec…